Ethical considerations of digital therapeutics for mental health

Constantin Landers, Blanche Wies, Marcello Ienca

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

3 Scopus citations

Abstract

This chapter provides an overview of the ethical issues that arise when healthcare practitioners (HCPs) prescribe or recommend digital therapeutics, in particular for treating mental health and addiction issues. We show that the lack of adequate clinical validation and regulatory frameworks for digital therapeutics leaves HCPs with particularly high responsibility. We group ethical issues into those affecting patients directly, those arising for society, and HCPs’ new roles and responsibilities. We identify privacy, transparency, autonomy, lack of clinical validation, fairness, and equality, as well as HCP's changing responsibilities and roles as major ethical issues. We illustrate why these issues matter for patients and society, discuss how and where they occur in practice and provide suggestions on what HCPs can practically do about these issues. We argue that HCPs have high overall responsibility and should pay special attention to ethical issues when recommending digital therapeutics or using them with their patients.

Original languageEnglish
Title of host publicationDigital Therapeutics for Mental Health and Addiction
Subtitle of host publicationThe State of the Science and Vision for the Future
PublisherElsevier
Pages205-217
Number of pages13
ISBN (Electronic)9780323900454
ISBN (Print)9780323885614
DOIs
StatePublished - 1 Jan 2022
Externally publishedYes

Keywords

  • Addiction
  • Autonomy
  • Clinical validation
  • Depression
  • Digital Therapeutics
  • Doctor responsibility
  • HCP responsibility
  • Mental Health
  • Privacy
  • Transparency

Fingerprint

Dive into the research topics of 'Ethical considerations of digital therapeutics for mental health'. Together they form a unique fingerprint.

Cite this